Elevance Health (NYSE:ELV – Free Report) had its price target increased by Wells Fargo & Company from $557.00 to $600.00 in a research report sent to investors on Friday, Benzinga reports. Wells Fargo & Company currently has an overweight rating on the stock. Several other research firms have also recently issued reports on ELV. Royal […]
Truist Financial reissued their buy rating on shares of Elevance Health (NYSE:ELV – Free Report) in a report issued on Friday morning, Benzinga reports. Truist Financial currently has a $600.00 price objective on the stock, up from their prior price objective of $580.00. Several other analysts have also recently commented on the stock. Barclays lifted […]
Sage Mountain Advisors LLC boosted its holdings in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 12.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,055 shares of the company’s stock after buying an additional 113 shares […]
GAMMA Investing LLC purchased a new stake in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) during the fourth quarter, Holdings Channel reports. The fund purchased 1,554 shares of the company’s stock, valued at approximately $767,000. A number of other hedge funds and other institutional investors have also modified their holdings of the business. […]
Wedge Capital Management L L P NC lessened its position in Elevance Health, Inc. (NYSE:ELV – Free Report) by 4.3% during the 4th quarter, HoldingsChannel.com reports. The fund owned 63,606 shares of the company’s stock after selling 2,863 shares during the quarter. Wedge Capital Management L L P NC’s holdings in Elevance Health were worth […]